Contact Us



Nathan JP. Drug information – the systematic approach. J Pharm Pract. 2013;26:78-84.

Grossman S, Zerilli T. Health and medication information resources on the World Wide Web. J Pharm Pract. 2013;26:85-94.


Kirschenbaum HL, Zerilli T. Assessment of full-time faculty preceptors by colleges and schools of pharmacy in the United States and Puerto Rico. Am J Pharm Educ 2012;76:Article 148.

Nathan JP, Grossman S. Professional reading habits of pharmacists attending 2 educational seminars in New York City. J Pharm Pract. 2012;25:600-5.


Zerilli T, He A, Nathan JP, Grossman S. To substitute or not to substitute: That is the question. Pharm Times 2011;77:68,70,71.

Nathan JP, Schilit S, Zerilli T, Shah B, Plotkin P, Tykhonova I. Functions performed by paid pharmacy interns in hospitals in New York. Am J Health-Syst Pharm 2011;68:165-8.


Schilit S, Benzeroual KE. Silodosin: A selective alpha 1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clin Ther 2009; 31:2489-2502.

Rosenberg J, Schilit S, Nathan J, Zerilli T, Mcguire H. An update on the status of 89 drug information centers in the United States. Am J Health-Syst Pharm 2009;66:1718-22.

Nathan JP, Gim S. Responding to drug information requests. Am J Health Syst Pharm 2009; 66:706-711.


Rosenberg JM, Schilit S, Nathan JP. Which oral solid medications should be protected from light and/or moisture? Drug Topics 2008; 152(6):25-29.

Rosenberg JM, Domovich A, Nathan JP, Schilit S. Should an RX label require a use-by date or an expiration date? Drug Topics 2008; 152(3):68.

Nathan JP, Schilit S, Rosenberg JM. Can lactose-intolerant patients use lactose-containing medications? Drug Topics 2008; 152(2):11.


Zerilli T, Pyon EY. Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. Clin Ther 2007; 29:2614-2634.

Rosenberg JM, Zerilli T, Nathan JP, Mcguire H. Use of statins and gemfibrozil in patients with type 2 diabetes mellitus and cardiovascular risk factors attending adult day health care centers: an opportunity for pharmacists. Consult Pharm 2007; 22:38-44.

Ayrapetova N, Nathan JP. What are the right OTCs to treat cough associated with the common cold? Drug Topics 2007; 151(3):58-59.

Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother 2007; 41:777-782.

Rosenberg JM. Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disorders. Am J Health Syst Pharm 2007; 64(2 Suppl 1):S18-23.


Agojo MC, Zerilli T, Nathan JP, Cicero LA. What’s the latest in vaccine therapy? Drug Topics 2006; 150(23):39-40.

Wang F, Troutman WG, Seo T, Peak A, Rosenberg JM. Drug information education in doctor of pharmacy programs. Am J Pharm Educ 2006; 70(3):51.


Nathan JP, Cicero LA, Koumis T, Rosenberg JMR, Feifer S, Maltz F. Availability of and attitudes towards resources on alternative medicine products in the community pharmacy setting. J Am Pharm Assoc 2005; 45;734-739.

Nathan JP, Koumis T, Rosenberg JMR. Sublingual nitroglycerin – are we counseling patients properly? Drug Topics 2005; 149(17):16.

Koumis T, Samuel S. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther 2005; 27:377-392.

Koumis T, Nathan JP, Rosenberg JM. What is bioidentical HRT and is there evidence to support its use? Drug Topics 2005; 149(9):29.


Koumis T, Nathan JP, Rosenberg JM, Cicero LA. Strategies for the prevention and treatment of statin-induced myopathy: Is there a role for ubiquinone supplementation? Am J Health-Syst Pharm 2004; 61:515-519.

Shah M, Nathan JP, Koumis T, Rosenberg JM. Was the FDA justified in banning ephedra-containing products? Drug Topics 2004; 148(5):68,71.

Koumis T, Cicero LA, Nathan JP, Rosenberg JM. What are the current and emerging strategies to improve low HDL-C levels? Drug Topics 2004; 148(21):20-21.

Rosenberg JM, Koumis T, Nathan JP, Cicero LA, Mcguire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health-Syst Pharm 2004; 61:2023-2032.

Koumis T, Cicero LA, Nathan JP, Rosenberg JM. Directory of pharmacist-operated drug information centers in the United StatesÓ†ļ2003. Am J Health-Syst Pharm 2004; 61:2033-2042.

Cicero LA. Natural health care for women. Drug Store News Continuing Education Quarterly Fall 2004: 29-34.


Nathan JP, Castellanos J, Rosenberg JM, Cicero LA. Impact of aspirin on the gastrointestinal-sparing effects of cyclooxygenase-2 inhibitors. Am J Health-Syst Pharm 2003; 60:392-394.

Koumis T, Nathan JP, Rosenberg JM. What is the role of C- reactive protein in cardiovascular disease assessment and how do you treat elevated levels? Drug Topics 2003; 147(15):30.

Nathan JP, Cicero LA, Rosenberg JM. Should patients on doxycycline avoid dairy products? Drug Topics 2003; 147(20):21.

Rosenberg JM. View Point- Aspirin chemoprophylaxis: a call to action. Drug Topics 2003; 147(21):22.

Nathan JP, Rosenberg JM. Who should get the flu vaccine and who shouldn't? Drug Topics 2003; 147(22):28,30.

Cicero LA, Rosenberg JMR. Basic bibliography: Benign prostatic hyperplasia. Hosp Pharm 2003; 38(1):94-95.

Cicero LA. NYCPS Newsletter. November 2003; News From the IDIC – Seasonal affective disorder


Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc 2002; 42:200-205.

Cheng JWM, Fidler B, Rosenberg JM, Mihm L. Implementation of a capstone pharmacotherapeutics course in the entry-level Doctor of Pharmacy program. Pharmacy Education 2002; 2(3):107-116.

Nathan JP, Joa G, Roizen M, Rosenberg JM. Are sulfonamides, sulfones, sulfites, and sulfates contraindicated in patients with a reported “sulfa” allergy? Drug Topics 2002; 146(15):37.

Koumis T, Nathan JP, Rosenberg JM. Can grapefruit juice be safely taken with drugs? Drug Topics 2002; 146(20):19.

Cicero LA. NYCPS Newsletter. February 2002; News From the IDIC – Hypercalcemia of malignancy

Cicero LA. NYCPS Newsletter. April 2002; News From the IDIC – Mechanisms of drug interactions


Cicero LA. The nature and management of involuntary weight loss in the elderly. J Am Soc Consult Pharm (supplement 1) 2001; 16:1-8.

Cicero LA. Natural care for the prostate. Drug Store News Continuing Education Quarterly January-March 2001:38-42.

Cicero LA. NYCPS Newsletter. January/February 2001; News From the IDIC – Stroke

Grossman SS, Nathan JP, Rosenberg JM. Should bitter melon be used for the treatment of diabetes mellitus? Drug Topics 2001; 145(18):23.

Lim G, Phillips A, Chiny W, Rosenberg JM. What cough and cold medications can be taken safely during pregnancy? Drug Topics 2001; 145(9):29-30.


Cicero LA. NYCPS Newsletter. April/May 2000; News From the IDIC- Polypharmacy and the elderly

Cicero LA. NYCPS Newsletter. October 2000; News From the IDIC – HRT, women and heart disease

Cicero LA, Rosenberg JM, Miyashiro A, Maby JI. Megestrol acetate suspension for the treatment of involuntary weight loss in elderly nursing home residents: A retrospective chart review. Consult Pharm 2000; 15(8):811-814.

Nathan JP, Rosenberg JM. A survey of fee-for-service activities of drug information centers in the US. Hosp Pharm 2000; 35:837-840,896.

Nathan JP, Cicero LA, Rosenberg JM. Can insulin be administered via nonparenteral routes? Drug Topics 2000; 144(5):40.

Nathan JP, Castellanos JT, Rosenberg JM. Should folic acid be added to reduce risk for cardiovascular disease? Drug Topics 2000; 144(18):34.

Nathan JP, Rosenberg JM, Davis J. Pharmacy services. In: Long-Term Care Survey and Certification Guide. Markenson AJ, Hurley B. eds. Chapel Hill, NC: Eli Research, Inc; 2000:1501-1541.

Plakogiannis R, Nathan JP, Rosenberg JM. How are insulin glargine and insulin aspart different from the older insulins? Drug Topics 2000; 144(22):41.